Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02160470 · ClinicalTrials.gov registry record · Phase 1
Enhancing Exposure Therapy for Snake and Spider Phobias
A Phase 1 study, sponsored by University of Texas at Austin.
- Completed
- Registry status
- Phase 1
- Development phase
- 120
- Enrollment target
NCT02160470 is a Phase 1 study that has completed, run by University of Texas at Austin. The registered enrollment target is 120 participants.
The verdict
NCT02160470, a Phase 1 study, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 120 participants
- Enrollment target
Study Summary
This study tests whether exposure therapy for fear of snakes or spiders is enhanced by the addition of a brief fear retrieval trial prior to treatment, and the use of compound extinction during treatment. The goal of the study is to determine whether these behavioral techniques enhance the efficacy of exposure therapy, one of the most empirically supported treatments for anxiety disorders.
Interventions
- BEHAVIORAL Exposure Therapy with Retrieval
- BEHAVIORAL Exposure Therapy with Compound Extinction
- BEHAVIORAL Exposure Therapy with Retrieval and Compound Extinction
- BEHAVIORAL Therapist-guided Exposure Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2012-08 |
| Est. Completion | 2019-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02160470
The ClinicalTrials.gov registry entry for NCT02160470 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Exposure Therapy with Retrieval is the first listed.
NCT02160470 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02160470 about?
NCT02160470 is a clinical study titled "Enhancing Exposure Therapy for Snake and Spider Phobias". This study tests whether exposure therapy for fear of snakes or spiders is enhanced by the addition of a brief fear retrieval trial prior to treatment, and the use of compound extinction during treatment. The goal of the study is to determine whether these behavioral techniques enhance the efficacy ...
What is the current status of trial NCT02160470?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 120 participants. The study started on 2012-08. Estimated completion is 2019-12.
What interventions are being tested in trial NCT02160470?
The interventions under investigation include: Exposure Therapy with Retrieval (BEHAVIORAL), Exposure Therapy with Compound Extinction (BEHAVIORAL), Exposure Therapy with Retrieval and Compound Extinction (BEHAVIORAL), Therapist-guided Exposure Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02160470?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.